Wearable Drug Delivery Devices Market To Hit USD 34.10 Billion By 2032 Powered By Rising Demand For Connected Healthcare SNS Insider

2025-12-03 08:32:18

(MENAFN- GlobeNewsWire - Nasdaq) The global wearable drug delivery devices market growth is driven by rising chronic diseases and advanced connected healthcare solutions. North America leads while Asia Pacific delivers the fastest growth momentum.

Austin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Wearable Drug Delivery Devices Market

Get a Sample Report of Wearable Drug Delivery Devices Market:

Wearable drug delivery devices are critical in modern healthcare, enabling continuous, precise, and patient-friendly drug administration for conditions like diabetes, cancer, and autoimmune disorders. Their rising adoption is fueled by the global surge in chronic diseases, which account for 74% of annual deaths worldwide. Devices like insulin pumps demonstrate their efficacy, improving glycemic control by up to 20% compared to conventional methods.

Supportive regulatory pathways are accelerating this innovation. The U.S. FDA, through expedited channels, has cleared multiple systems for biologics and long-term care, such as West Pharmaceutical's SmartDose platform. This regulatory momentum, combined with the proven clinical benefits of products like Amgen's Neulasta Onpro, is rapidly integrating these advanced technologies into mainstream disease management, reducing clinical dependence and enhancing patient outcomes.

Wearable Drug Delivery Devices Market Report Scope

Report Attributes	Details
Market Size in 2024	USD 19.56 Billion
Market Size by 2032	USD 34.10 Billion
CAGR	CAGR of 7.19% From 2025 to 2032
Base Year	2024
Forecast Period	2025-2032
Historical Data	2021-2023
Key Segments	. By Product Type (Patch Injectors, Insulin Pumps, Microneedle Devices, Infusion Pumps) . By Technology (Mechanical Devices, Electromechanical Devices, Microfluidic Devices) . By Application (Diabetes Management, Cancer Treatment, Cardiovascular Diseases, Pain Management, Others) . By End User (Hospitals and Clinics, Home Care Settings, Ambulatory Care Centers)
Regional Analysis/Coverage	North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).

Segmentation Analysis:

By Product Type

In 2024, Insulin Pumps held the largest share of the wearable drug delivery devices market, accounting for 45% of the total market share. The dominance of insulin pumps is due to the increasing prevalence of diabetes, particularly type 1 and type 2, and the growing demand for better glucose control. The Microneedle Devices segment is the fastest-growing within wearable drug delivery devices throughout the forecast period due to its non-invasive, painless, and highly efficient drug delivery methods.

By Technology

In 2024, Electromechanical devices dominated the technology segment, capturing 55% of the wearable drug delivery device market share as these devices combine mechanical components with electrical elements, offering precise, automated drug delivery and real-time monitoring capabilities. The microfluidic devices segment is the fastest-growing technology as these devices offer precise control of fluid delivery at a microscopic scale, making them ideal for biologics, personalized medicine, and high-precision treatments.

Purchase Single User PDF of Wearable Drug Delivery Devices Market Report:

Regional Insights:

In 2024, North America dominated the wearable drug delivery devices market, accounting for the largest share due to the high prevalence of chronic diseases, particularly diabetes, and the strong healthcare infrastructure.

Asia Pacific is the fastest-growing region in the market, driven by increasing healthcare expenditure, rising awareness of chronic diseases, and a large patient population.

Major Players Analysis Listed in the Wearable Drug Delivery Devices Market Report Are:

Medtronic
Insulet Corporation
Johnson and Johnson (Janssen Pharmaceuticals)
AbbVie
Tandem Diabetes Care
Roche
Viomedex
Elcam Medical
West Pharmaceutical Services
Biocorp
Becton Dickinson
Zogenix
Syris
Fresenius Kabi
Novo Nordisk
Antares Pharma
Lilly
SteadyMed Therapeutics
Ypsomed
Other players

Recent Developments:

In Oct 2024, Anne Staples was awarded the National Institutes of Health Trailblazer Award for developing lightweight drug delivery devices. This funding from the National Institute of Biomedical Imaging and Bioengineering aims to address the issue of bulky wearable devices by creating more compact alternatives for patients.

For a Personalized Briefing with Our Industry Analysts, Connect Now:

Exclusive Sections of the Report (The USPs):

EFFICIENCY & PERFORMANCE METRICS – helps you evaluate drug delivery accuracy, device reliability rates, and the supported duration of continuous infusion, enabling assessment of clinical performance and technological maturity across wearable systems.
ADOPTION & IMPLEMENTATION METRICS – helps you understand patient adoption levels across key therapy areas, measure the penetration of smart/connected wearables, and compare hospital vs. home-care usage to identify demand hotspots.
ECONOMIC & MARKET VALUE INDICATORS – helps you analyze global market revenue trends, device cost variations across product types, and revenue contributions from different distribution channels for strategic pricing and market penetration planning.
PATIENT-CENTRIC & REGULATORY BENCHMARKS – helps you track improvements in patient adherence, regulatory clearance rates (FDA, EMA, etc.), and user satisfaction metrics to evaluate safety, usability, and compliance readiness.
TECHNOLOGICAL INTEGRATION & CONNECTIVITY INDEX – helps you assess the penetration of Bluetooth, cloud-enabled, and mHealth-integrated devices, providing insights into digital transformation and remote monitoring opportunities in drug delivery.
CARE-SETTING SHIFT & UTILIZATION SCORECARD – helps you measure the transition from traditional clinical settings to home-based drug administration, revealing new growth opportunities and the evolving care delivery ecosystem.

Related Reports

Wearable Medical Devices Market Forecast

Insulin Pump Market Outlook

Microneedle Drug Delivery Systems Market Report

Diabetes Devices Market Insight

Home Healthcare Devices Market Overview

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email:...

MENAFN03122025004107003653ID1110431447

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.